MALVERN, Pa., Feb. 25, 2013 /PRNewswire/ --
"Rajiv is a strong leader with the deep industry experience, outcome-oriented approach, and proven ability to drive results the Board was seeking in our next CEO," said Roger H. Kimmel, Chairman of the Board. "His track record in generating growth and profitability, managing complex integrations, and delivering for shareholders will serve us well. We are focused on taking the actions needed to create value for Endo shareholders and believe today's announcement is another key step forward that will enable us to build on Endo's strong foundation. At the same time, we appreciate Dave Holveck's significant contributions to Endo, including his leadership in reducing the Company's dependence on Lidoderm, and wish him well in his retirement."
Said De Silva, "I am excited to take on the challenge of leading Endo and helping the Company realize its full potential. Endo occupies a unique position in the healthcare market, able to deliver innovative products and services across multiple platforms with clear strengths in the medically important areas of pain management and urology. I look forward to working with the Endo team to build on its strengths and deliver top line growth while also improving cost management, execution and integration to enable Endo to make the most of its many opportunities and create value for its shareholders."
Mr. De Silva, 46, has deep experience in the pharmaceutical sector. He most recently served as President of
Prior to joining Valeant, Mr. De Silva was a senior executive at
He currently serves on the
Conference Call and Webcast
Endo will host a conference call and webcast at 4:30 p.m. ET today. Investors and other interested parties may call (866)578-5771 (domestic) or (617) 213-8055 (international) and enter passcode 10495594. Please dial in 10 minutes prior to the scheduled start time.
A replay of the call will be available from February 25, 2013 at 6:30pm ET until 11:59pm ET on March 4, 2013by dialing (888) 286-8010 (domestic) or (617) 801-6888 (international) and entering passcode 57765730.
A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00pm ET on February 25, 2014. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.
About Endo
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" in our Form 10-K, Form 10-Q and Form 8-K filings with the
SOURCE